Khorana Risk Score for Venous Thromboembolism in Cancer Patients
Predicts risk of VTE for cancer patients depending on type of cancer and other factors.
376 entries · Page 7 of 13
Predicts risk of VTE for cancer patients depending on type of cancer and other factors.
Estimates GFR in patients with acutely changing creatinine.
Recommends who should be immediately referred for liver transplant.
Determines presence of IBS using clinically significant weighted criteria.
Quantifies both hemodialysis and peritoneal dialysis treatment adequacy.
Predicts 30-day readmission or death in patients on medicine and surgery wards.
Uses parent description of child’s activity to assess ability and response to treatment.
Calculates LDL based on total and HDL cholesterol and triglycerides.
Diagnoses rheumatoid arthritis in patients with recent-onset undifferentiated arthritis.
Predicts probability of hydronephrosis on renal ultrasonography (RUS) requiring urologic intervention in adult patients with acute kidney injury.
Determines if pleural fluid is exudative or transudative.
Predicts mortality in patients with alcoholic hepatitis not responding to steroid therapy.
Screens for necrotizing soft tissue infections.
Identifies patients at high risk for developing acute lung injury (ALI).
Predicts prognosis and steroid benefit in alcoholic hepatitis.
Calculates maintenance fluid requirements by weight.
Screens for depression based on clinically significant questions.
Identifies patients who are malnourished or at risk of malnutrition.
Determines likelihood of irritable bowel syndrome diagnosis based on clinically significant criteria.
Rules out coronary artery disease in primary care patients with chest pain.
Identifies patients at low risk for poor outcome with febrile neutropenia.
Assesses severity of ulcerative colitis.
Estimates GFR in CKD patients using creatinine and patient characteristics.
Predicts risk of contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI).
Predicts metastatic renal cell carcinoma survival, more accurately than the Motzer Score.
Quantifies end-stage liver disease for transplant planning with sodium.
Quantifies end-stage liver disease for transplant planning.
Adds sodium to the MELD model for liver cirrhosis.
Predicts risk of type 2 diabetes in previously undiagnosed patients.
No entries match your filter.